Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$41.75 - $54.5 $4,175 - $5,450
100 Added 1.98%
5,151 $264,000
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $86,742 - $111,428
-2,210 Reduced 30.44%
5,051 $217,000
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $4,596 - $5,207
128 Added 1.79%
7,261 $284,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $8,372 - $9,442
-250 Reduced 3.39%
7,133 $258,000
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $4,183 - $5,320
125 Added 1.72%
7,383 $271,000
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $11,906 - $13,968
375 Added 5.45%
7,258 $266,000
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $23,164 - $33,097
857 Added 14.22%
6,883 $224,000
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $11,949 - $13,561
-363 Reduced 5.68%
6,026 $236,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $51,771 - $58,128
-1,400 Reduced 17.97%
6,389 $276,000
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $3,600 - $3,955
96 Added 1.25%
7,789 $330,000
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $192 - $219
5 Added 0.07%
7,693 $335,000
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $12,512 - $15,177
363 Added 4.96%
7,688 $339,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $17,644 - $18,810
535 Added 7.88%
7,325 $266,000
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $34,558 - $40,092
-1,083 Reduced 13.76%
6,790 $240,000
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $3,326 - $3,529
-100 Reduced 1.25%
7,873 $285,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $36,673 - $40,399
1,183 Added 17.42%
7,973 $285,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,790
6,790 $228,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fairview Capital Investment Management, LLC Portfolio

Follow Fairview Capital Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairview Capital Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairview Capital Investment Management, LLC with notifications on news.